A Retrospective Study of Chinese Patients With Giant Cell Arteritis (GCA)

AbstractA retrospective study was performed on 70 giant cell arteritis (GCA) patients in Peking Union Medical College Hospital (PUMCH). The aim of this study was to describe the clinical features of these Chinese GCA patients and explore the possible associated factors for severe ischemic manifestations. Medical charts of all patients were reviewed, and the demographic, clinical, and laboratory data were analyzed. The mean age at disease onset was 65.2 years old, and the ratio of male to female was 1:1. Fever and headache were most prominent symptoms at onset, which occurred in 51.4% and 30.0% of patients, respectively. Common manifestations at diagnosis were constitutional symptoms (85.7%), headache (68.8%), visual impairment (38.6%), jaw claudication (30%), scalp tenderness (30%), and concurrent polymyalgia rheumatic (27.1%). No significant difference in clinical manifestations between genders was observed. Comparisons between patients with and without severe ischemic manifestations including jaw claudication, permanent visual loss, or cerebrovascular accident had shown that fever and asthenia were significantly less frequent in patients with severe ischemic manifestations (P = 0.006 and 0.023, respectively), and the mean value of erythrocyte sedimentation rate (ESR) was significantly lower in patients with severe ischemic manifestations than patients without (P = 0.001). History of smoking was more frequent in patients with severe ischemic manifestations (P = 0.038).This is the largest group of GCA patients from China so far. When compared our data with patients reported in the literature, this series of GCA patients were younger and without female predominance. The clinical manifestations of patients in this report were similar to other studies except for a higher prevalence of constitutional symptoms. The results of this study indicated that lower systemic inflammatory response and the history of smoking might be associated with severe ischemic damages.

[1]  B. Dasgupta,et al.  Imaging in Giant Cell Arteritis , 2015, Current Rheumatology Reports.

[2]  C. Weyand,et al.  Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. , 2014, The New England journal of medicine.

[3]  G. Nesher.  The diagnosis and classification of giant cell arteritis. , 2014, Journal of autoimmunity.

[4]  S. Shinjo,et al.  Giant cell arteritis: a multicenter observational study in Brazil , 2013, Clinics.

[5]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[6]  G. Hunder,et al.  Clinical features of polymyalgia rheumatica and giant cell arteritis , 2012, Nature Reviews Rheumatology.

[7]  M. Gershwin,et al.  Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. , 2012, Autoimmunity reviews.

[8]  C. Salvarani,et al.  Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study. , 2012, Rheumatology.

[9]  M. González-Gay,et al.  Giant Cell Arteritis: Epidemiology, Diagnosis, and Management , 2010, Current rheumatology reports.

[10]  T. Porco,et al.  Giant cell arteritis in Asians: a comparative study , 2007, British Journal of Ophthalmology.

[11]  Javier Martín,et al.  Epidemiology of giant cell arteritis and polymyalgia rheumatica. , 2009, Arthritis and rheumatism.

[12]  O. Steichen.  Comment on: Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. , 2009, Rheumatology.

[13]  M. González-Gay,et al.  Strokes at Time of Disease Diagnosis in a Series of 287 Patients With Biopsy-Proven Giant Cell Arteritis , 2009, Medicine.

[14]  C. Hess,et al.  High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. , 2009, Rheumatology.

[15]  D. Formisano,et al.  Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. , 2009, Rheumatology.

[16]  M. González-Gay,et al.  Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. , 2006, Medicine.

[17]  Javier Martín,et al.  Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. , 2006, Medicine.

[18]  D. Consonni,et al.  Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. , 2005, Arthritis and rheumatism.

[19]  M. González-Gay,et al.  Influence of Traditional Risk Factors of Atherosclerosis in the Development of Severe Ischemic Complications in Giant Cell Arteritis , 2004, Medicine.

[20]  M. González-Gay,et al.  Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population. , 2004, Arthritis and rheumatism.

[21]  Zhiping Hu,et al.  Cerebral Infarction Due to Giant Cell Arteritis , 2004, Angiology.

[22]  Ronit Nesher,et al.  Risk Factors for Cranial Ischemic Complications in Giant Cell Arteritis , 2004, Medicine.

[23]  K. Yasuda,et al.  Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. , 2003, Arthritis and rheumatism.

[24]  H. Kleinman,et al.  Tissue and Serum Angiogenic Activity Is Associated With Low Prevalence of Ischemic Complications in Patients With Giant-Cell Arteritis , 2002, Circulation.

[25]  Zhiping Hu,et al.  Giant cell arteritis in China: a prospective investigation. , 2002, Angiology.

[26]  R. Nir-Paz,et al.  Sex differences in giant cell arteritis. , 2002, The Journal of rheumatology.

[27]  G. Smetana,et al.  Does this patient have temporal arteritis? , 2002, JAMA.

[28]  F. Herrmann,et al.  Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. , 2001, The American journal of medicine.

[29]  Zhiping Hu,et al.  Temporal Arteritis and Fever: Report of a Case and a Clinical Reanalysis of 360 Cases , 2000, Angiology.

[30]  A. Hajeer,et al.  Visual Manifestations of Giant Cell Arteritis: Trends and Clinical Spectrum in 161 Patients , 2000, Medicine.

[31]  W. Ollier,et al.  The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. , 1999, The Journal of rheumatology.

[32]  R. Loire,et al.  Giant cell arteritis and cardiovascular risk factors : A multicenter, prospective case-control study , 1998 .

[33]  E. Dudenhoefer,et al.  Scalp necrosis with giant cell arteritis. , 1998, Ophthalmology.

[34]  A. de la Sierra,et al.  Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. , 1998, Arthritis and rheumatism.

[35]  R. Loire,et al.  Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. , 1998, Arthritis and rheumatism.

[36]  J. Gran,et al.  A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. , 1997, British journal of rheumatology.

[37]  R. Kay,et al.  Giant cell arteritis in two Chinese patients. , 1991, Australian and New Zealand journal of medicine.

[38]  C. Salvarani,et al.  Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. , 1991, Arthritis and rheumatism.

[39]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.

[40]  S. Gabriel,et al.  A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? , 1989, International journal of epidemiology.

[41]  L. A. Healey,et al.  Giant cell arteritis in two Chinese patients. , 1984, Arthritis and rheumatism.

[42]  G. Hunder,et al.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. , 1982, Annals of internal medicine.